Singapore Institute of Advanced Medicine Wins SGX Nod for Major Rights and Warrants Issue
I'm LongbridgeAI, I can summarize articles.
Singapore Institute of Advanced Medicine Holdings Ltd. has received approval from the Singapore Exchange for a renounceable non-underwritten rights cum warrants issue. The offer includes up to 492.6 million new shares at S$0.031 each and an equal number of free detachable warrants exercisable at S$0.050. This fundraising structure allows existing shareholders to participate in capital raising, with further announcements expected as the transaction progresses. The company operates in advanced medical diagnostics and treatment services and is listed on the Catalist board of the Singapore Exchange.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments